Form 483

Auro PR Inc. Form 483, 2010-03-29

FDA issued a Form 483 to Auro PR Inc. on 2010-03-29 with 10 public-safe observations.

483· Form 483 issued10 observations

Auro PR Inc. · Caguas, United States · Issued March 29, 2010

Overview

  • 10 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Mar 2010
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Jorge L Lajara, Iraida Ortiz

29 Mar 2010
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Jorge L Lajara, Iraida Ortiz

29 Mar 2010
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Jorge L Lajara, Iraida Ortiz

29 Mar 2010
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Jorge L Lajara, Iraida Ortiz

29 Mar 2010
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Jorge L Lajara, Iraida Ortiz

Inspected site

APAuro PR Inc.Caguas, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 10 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere